New Castle, DE —April 29, 2025 —ABS Bio is pleased to welcome Libu Mathew, CPA as Chief Financial Officer (CFO).
Libu joins ABS from NJ Bio where he also served as CFO during a period that saw the company’s revenue grow by more than 2000%. NJ Bio is a leading Contract Research Organization (CRO)/ Contract Development and Manufacturing Organization (CDMO) headquartered in Princeton, NJ, with locations in Bristol, PA and Mumbai, India. Prior to NJ Bio, Libu held Financial Controller positions at Cello Health and Abzena.
“As ABS Bio is expanding on multiple fronts, Libu is playing an important role in strengthening our executive team. His efforts to date have already made significant impacts on our financial operations, systems and controls, and his leadership is helping make the entire organization more efficient and productive,” commented ABS Bio Founder & CEO, Charlie Saller, Ph.D.
Libu earned his Bachelors in Business Administration, Accounting at Drexel University in Philadelphia and is a Certified Public Accountant (CPA).
